Working… Menu
Trial record 1 of 1 for:    D933GC00001- EMERALD
Previous Study | Return to List | Next Study

A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma (EMERALD-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03778957
Recruitment Status : Recruiting
First Posted : December 19, 2018
Last Update Posted : November 16, 2021
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 19, 2022
Estimated Study Completion Date : August 19, 2024